Abstract
The properties of bone marrow (BM)-derived multipotent mesenchymal stromal cells (MSCs) are altered in the patients with the diffuse large B cell lymphoma (DLBCL) without BM involvement. It was suggested that plasma from the patients contains soluble factors that affect MSCs. Plasma and BM-derived MSCs from the DLBCL patients at the onset of the disease and one month after the end of treatment were studied. Concentration of the plasma cytokines and gene expression in the MSCs were evaluated by the Bio-Plex Pro Human Cytokine Panel kit to measure 27 analytes and real-time PCR. Plasma and MSCs from the healthy donors were used as controls. Analysis of cytokines in the plasma from healthy donors and patients before and one month after the end of treatment revealed significant differences in the concentration of 14 out of 27 cytokines. Correlations between the levels of secreted cytokines were altered in the plasma from patients indicating that the immune response regulation was disturbed. Cultivation of the MSCs from the healthy donors in the medium supplemented with the plasma from patients led to the changes in the MSC properties, similar to those observed in the MSCs from patients. The BM-derived MSCs were shown to participate in the humoral changes occurring in the DLBCL patients. For the first time, it was shown that the precursors of the stromal microenvironment – multipotent mesenchymal stromal cells – are altered in the patients with DLBCL without bone marrow involvement due to the humoral effect of the tumor and the response of organism to it. Comprehensive analysis of the results shows that, when remission is achieved in the patients with DLBCL, composition of the plasma cytokines normalizes, but does not reach the level observed in the healthy donors. The discovery of a new aspect of the effect of the tumor B-cells on the organism could help to reveal general regularities of the humoral effect of various tumors on the bone marrow stromal cells.
Similar content being viewed by others
Abbreviations
- BM:
-
bone marrow
- CFU-F:
-
colony-forming unit of fibroblasts
- DLBCL:
-
diffuse large B-cell lymphoma
- IFN-γ:
-
interferon gamma
- IL:
-
interleukin
- MFI:
-
mean fluorescence intensity
- MSC:
-
multipotent mesenchymal stromal cells
- PDT:
-
population doubling time
- REL:
-
relative expression level
- TNF-α:
-
tumor necrosis factor alpha
References
Beltran, B. E., Quiñones, P., Morales, D., Malaga, J. M., Chavez, J. C., et al. (2018) Response and survival benefit with chemoimmunotherapy in Epstein–Barr virus-positive diffuse large B-cell lymphoma, Hematol. Oncol., 36, 93-97, https://doi.org/10.1002/hon.2449.
Swerdlow, S. H., World Health Organization, International Agency for Research on Cancer (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4t. Lyon: International Agency for Research on Cancer, 2017.
Fastova, E. A., Magomedova, A. U., Petinati, N. A., Sats, N. V., Kapranov, N. M., et al. (2019) Bone marrow multipotent mesenchymal stromal cells in patients with diffuse large B-cell lymphoma, Bull. Exp. Biol. Med., 167, 150-153, https://doi.org/10.1007/s10517-019-04480-6.
Chen, Q., Yuan, Y., and Chen, T. (2014) Morphology, differentiation and adhesion molecule expression changes of bone marrow mesenchymal stem cells from acute myeloid leukemia patients, Mol. Med. Rep., 9, 293-298, https://doi.org/10.3892/mmr.2013.1789.
Shipounova, I. N., Petrova, T. V, Svinareva, D. A., Momotuk, K. S., Mikhailova, E. A., and Drize, N. I. (2009) Alterations in hematopoietic microenvironment in patients with aplastic anemia, Clin. Transl. Sci., 2, 67-74, https://doi.org/10.1111/j.1752-8062.2008.00074.x.
Kotyza, J. (2017) Chemokines in tumor proximal fluids, Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub., 161, 41-49, https://doi.org/10.5507/bp.2016.062.
Vilgelm, A. E., and Richmond, A. (2019) Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy, Front. Immunol., 10, 333, https://doi.org/10.3389/fimmu.2019.00333.
Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008) Cancer-related inflammation, Nature, 454, 436-444, https://doi.org/10.1038/nature07205.
Okrój, M., and Potempa, J. (2019) Complement activation as a helping hand for inflammophilic pathogens and cancer, Front. Immunol., 9, 3125, https://doi.org/10.3389/fimmu.2018.03125.
Lund, F. E. (2008) Cytokine-producing B lymphocytes-key regulators of immunity, Curr. Opin. Immunol., 20, 332-338, https://doi.org/10.1016/j.coi.2008.03.003.
Munir, H., Ward, L. S. C., and McGettrick, H. M. (2018) Mesenchymal stem cells as endogenous regulators of inflammation, Adv. Exp. Med. Biol., 1060, 73-98, https://doi.org/10.1007/978-3-319-78127-3_5.
Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative CT method, Nat. Protoc., 3, 1101-1108, https://doi.org/10.1038/nprot.2008.73.
Metcalf, D. (2008) Hematopoietic cytokines, Blood, 111, 485-491, https://doi.org/10.1182/blood-2007-03-079681.
Metcalf, D., Willson, T. A., Hilton, D. J., Di Rago, L., and Mifsud, S. (1995) Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays, Leukemia, 9, 1556-1564.
Lyman, G. H., and Dale, D. C. (2010) Introduction to the Hematopoietic Growth Factors, Springer, Boston, MA, pp. 3-10.
Lenert, P., Brummel, R., Field, E. H., and Ashman, R. F. (2005) TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production, J. Clin. Immunol., 25, 29-40, https://doi.org/10.1007/s10875-005-0355-6.
Ma, N., Zhang, Y., Liu, Q., Wang, Z., Liu, X., et al. (2017) B cell activating factor (BAFF) selects IL-10-B cells over IL-10+B cells during inflammatory responses, Mol. Immunol., 85, 18-26, https://doi.org/10.1016/j.molimm.2017.02.002.
Li, L., Zhang, J., Chen, J., Xu-Monette, Z. Y., Miao, Y., et al. (2018) B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma, Blood, 132, 1805-1817, https://doi.org/10.1182/blood-2018-03-841015.
Portnow, J., Badie, B., Liu, X., Frankel, P., Mi, S., et al. (2014) A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent, J. Neurooncol., 118, 169-177, https://doi.org/10.1007/s11060-014-1415-4.
Cheng, H., Sun, G., and Cheng, T. (2018) Hematopoiesis and microenvironment in hematological malignancies, Cell Regen., 7, 22-26, https://doi.org/10.1016/j.cr.2018.08.002.
Zhong, W., Zhu, Z., Xu, X., Zhang, H., Xiong, H., et al. (2019) Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels, J. Exp. Clin. Cancer Res., 38, 73, https://doi.org/10.1186/s13046-019-1081-7.
Petinati, N. A., Sats, N., Drize, N. J., Malyants, I., Shender, V., et al. (2019) Alterations in secretome and transcriptome of bone marrow derived MSCs in patients with diffuse large B-cell lymphoma without bone marrow involvement, Blood, 134, 1514-1514, https://doi.org/10.1182/blood-2019-122431.
Acknowledgements
The authors are grateful to O. Pshenichnikova for a productive discussion of the materials of this work.
Funding
This work was supported by the Russian Foundation for Basic Research (project no. 17-04-00170).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest in financial or any other sphere. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Petinati, N.A., Bigildeev, A.E., Karpenko, D.S. et al. Humoral Effect of a B-Cell Tumor on the Bone Marrow Multipotent Mesenchymal Stromal Cells. Biochemistry Moscow 86, 207–216 (2021). https://doi.org/10.1134/S0006297921020097
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297921020097